HelixBioDx operates a CAP‑accredited molecular diagnostics laboratory that provides multiplex real‑time PCR panels for infectious diseases, delivering next‑day, quantitative results through a secure, HIPAA‑compliant portal. The service enables skilled nursing and long‑term care facilities to quickly identify pathogens, support antimicrobial stewardship, and streamline Medicare/Medicaid billing, thereby reducing unnecessary antibiotic use and readmissions.
Funding
Funding not disclosed
Founders
Product
Problem
Skilled nursing facilities often rely on conventional culture methods that take several days to return results, delaying targeted antimicrobial therapy and contributing to unnecessary antibiotic use, higher readmission rates, and increased risk of resistance.
Solution
HelixBioDx operates a College of American Pathologists‑accredited molecular diagnostics laboratory that processes multiplex real‑time PCR panels and delivers clinically validated results by the next business day. The service covers a comprehensive suite of infectious disease panels—including gastrointestinal, respiratory, wound, urinary, Group A Strep, C. diff, and SARS‑CoV‑2—enabling clinicians to identify pathogens within hours rather than days. Results are transmitted via a secure, HIPAA‑compliant portal with detailed quantitative reporting that aligns with Medicare and Medicaid billing requirements. By providing rapid, high‑sensitivity diagnostics, HelixBioDx supports evidence‑based antimicrobial stewardship, reduces empiric antibiotic prescribing, and helps lower hospital readmissions for long‑term care residents.
Target Audience
The primary customers are skilled nursing and long‑term care facilities that require rapid, reimbursable infectious‑disease diagnostics to guide antimicrobial therapy and reduce readmissions.
Features
- CAP accreditation and CLIA‑compliant laboratory operations ensuring regulatory compliance and quality assurance
- Next‑day turnaround for all PCR panels through a high‑throughput, multiplex real‑time PCR platform
- Broad panel portfolio: gastrointestinal (including C. diff), respiratory (including lower respiratory and sputum), wound, urine, Group A Strep, COVID‑19, and microalbumin
- Automated result generation with quantitative pathogen load, antimicrobial susceptibility inference, and trend analytics
- Secure, encrypted web portal delivering PDF and HL7‑compatible reports for seamless integration with EHR systems
- Medicare and Medicaid coverage eligibility built into the ordering workflow to simplify reimbursement
- Scalable logistics network supporting nationwide skilled nursing facilities with dedicated sample collection kits and tracking